Novartis Ag Adr (NVS)

Feb 06, 2026

Novartis ADR earnings beat by $0.06, revenue fell short of estimates - Investing.com Nigeria

Feb 06, 2026

Feb 05, 2026

Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead - Sahm

Feb 05, 2026

Feb 05, 2026

Novartis' Strong Innovation Supports Industry-Leading Margins - morningstar.com

Feb 05, 2026

Feb 04, 2026

Novartis stock hits all-time high at 153.83 USD By Investing.com - Investing.com Australia

Feb 04, 2026

Feb 04, 2026

Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead - Benzinga

Feb 04, 2026

Feb 04, 2026

Novartis Beats on Q4 Earnings, Entresto Generics Pressure Sales - Finviz

Feb 04, 2026

Feb 04, 2026

Novartis stock hits all-time high at 153.83 USD - Investing.com

Feb 04, 2026

Feb 04, 2026

Earnings call transcript: Novartis Q4 2025 earnings beat forecasts, stock jumps - Investing.com

Feb 04, 2026

Feb 03, 2026

Peering Into Novartis AG's Recent Short Interest - Sahm

Feb 03, 2026

Jan 31, 2026

Why Analysts Are Closely Watching Novartis AG (NVS) - Finviz

Jan 31, 2026

Jan 28, 2026

Jim Cramer is Optimistic About Novartis' (NVS) Cancer Drug - Finviz

Jan 28, 2026

Jan 26, 2026

Corticosteroids Market Report 2026 - GlobeNewswire Inc.

Jan 26, 2026

Jan 24, 2026

Novartis Positions US Strategy As Defense Against Rising Trade Levies - Sahm

Jan 24, 2026

Jan 24, 2026

Novartis stock hits all-time high at $146.4 By Investing.com - Investing.com South Africa

Jan 24, 2026

Jan 23, 2026

Novartis stock hits all-time high at $146.4 - Investing.com

Jan 23, 2026

Jan 23, 2026

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock Backed by Strong Fundamentals - Chartmill

Jan 23, 2026

Jan 23, 2026

Oncolytic Virotherapy Market - GlobeNewswire Inc.

Jan 23, 2026

Jan 21, 2026

Novartis ADR: Defensive Giant Tests Investor Patience As Rally Cools - AD HOC NEWS

Jan 21, 2026

Jan 20, 2026

Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case - Chartmill

Jan 20, 2026

Jan 20, 2026

Novartis AG (NVS) Advances $23B U.S. Investment Plan With New RLT Logistics Hub - Finviz

Jan 20, 2026

Jan 18, 2026

The Truth About Novartis AG (ADR): Why Everyone Is Suddenly Watching This Pharma Giant - AD HOC NEWS

Jan 18, 2026

Jan 12, 2026

Is Novartis AG Gaining or Losing Market Support? - Sahm

Jan 12, 2026

Jan 11, 2026

3 Dividend Stocks to Buy in 2026 and Hold Forever - Finviz

Jan 11, 2026

Jan 09, 2026

Enliven Therapeutics Early Leukemia Drug Results Impress, Stock Soars - Sahm

Jan 09, 2026

Jan 08, 2026

New Investors: 3 Stocks to Build Your Portfolio Around in 2026 - Finviz

Jan 08, 2026

Jan 05, 2026

The Truth About Novartis AG (ADR): Is Wall Street’s Quiet Giant Your Next Power Play? - AD HOC NEWS

Jan 05, 2026

Jan 04, 2026

The Truth About Novartis AG: Is This Pharma Giant a Silent Stock Cheat Code? - AD HOC NEWS

Jan 04, 2026

Jan 04, 2026

Novartis AG (ADR): Quiet Confidence Or Complacency? A Deep Look At NVS After A Steady Climb - AD HOC NEWS

Jan 04, 2026

Jan 01, 2026

Novartis AG (NYSE:NVS) Stands Out as a Dependable Dividend Stock with Strong Fundamentals - Chartmill

Jan 01, 2026

Dec 29, 2025

7 Newly Overvalued Stocks this Week - Morningstar

Dec 29, 2025

Dec 27, 2025

EBITDA per share of Novartis AG ADR Cert Deposito Arg Repr 0.25 ADRs – BCBA:NVSC - TradingView — Track All Markets

Dec 27, 2025

Dec 26, 2025

NVS Price History for Novartis Ag ADR Stock - Barchart.com

Dec 26, 2025

Dec 22, 2025

2 Top Stocks to Buy and Hold for the Long Term - Finviz

Dec 22, 2025

Dec 19, 2025

Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Sahm

Dec 19, 2025

Dec 19, 2025

Pharma's $370B Bet on America: The ETF Plays for 2026 - Barchart.com

Dec 19, 2025

Dec 18, 2025

White House Readies Drug Price Deals With AbbVie, Novartis, Roche - Sahm

Dec 18, 2025

Dec 17, 2025

Novartis, Roche to reach drug pricing deal with White HouseBloomberg - Investing.com

Dec 17, 2025

Dec 15, 2025

HSBC Lifts PT on Novartis AG (NVS) to $112 From $106 - Finviz

Dec 15, 2025